文献速递肿瘤 PET/CT甲状腺核医学

68Ga-NY104 PET/CT在疑似肾肿块评估中意外发现CAIX高摄取乳腺浸润性导管癌

Incidental Detection of a CAIX-avid Breast Invasive Ductal Carcinoma on 68 Ga-NY104 PET/CT During Evaluation of a Suspected Renal Mass.
PubMed 文献 · Clin Nucl Med · 2026-03-25

本文报道一例55岁女性疑似左肾肿块患者行68Ga-NY104 PET/CT,肾肿块未见明显摄取,但左乳意外发现高摄取结节;后续18F-FDG PET/CT显示肾肿块轻度摄取、乳腺结节高摄取;术后病理证实肾肿块为良性血管平滑肌脂肪瘤,乳腺结节为浸润性导管癌。本病例提示应将原发性乳腺癌纳入肾外CAIX高摄取病变的鉴别诊断。

要点

  • 68Ga-NY104 PET/CT在疑似肾肿块评估中可意外发现肾外CAIX高摄取病变。
  • 肾外CAIX高摄取病灶的鉴别诊断应包括原发性乳腺癌。
  • 68Ga-NY104肾肿块无显著摄取而病理为良性血管平滑肌脂肪瘤。

核心结论

  • 68Ga-NY104 PET/CT评估疑似肾肿块时意外发现左乳CAIX高摄取结节,术后病理证实为浸润性导管癌。
  • 肾外CAIX高摄取病变的鉴别诊断应纳入原发性乳腺癌。

研究设计与样本

  • 单病例报告:55岁女性,疑似左肾肿块,行68Ga-NY104 PET/CT及后续18F-FDG PET/CT,并行术后病理确认。

主要发现

  • 68Ga-NY104 PET/CT示左肾肿块未见明显摄取,左乳意外发现高摄取结节。
  • 18F-FDG PET/CT示肾肿块轻度摄取、乳腺结节高摄取。
  • 术后病理证实肾肿块为良性血管平滑肌脂肪瘤,乳腺结节为浸润性导管癌。

临床怎么用

  • 68Ga-NY104 PET/CT发现肾外CAIX高摄取病灶时,应将原发性乳腺癌纳入鉴别诊断并进一步评估。

局限性

  • 单病例报告,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

68 Ga-NY104 is a novel tracer targeting carbonic anhydrase IX (CAIX) with promising diagnostic efficacy for clear cell renal cell cancer. We present a 55-year-old woman with a suspected left renal mass who underwent 68 Ga-NY104, showing no significant uptake in the renal mass but incidentally revealing an intense uptake nodule in the left breast. Subsequent 18 F-FDG PET/CT revealed mild renal mass and intense breast nodule uptake. Postoperative pathology confirmed the renal mass as benign angiomyolipoma and the breast nodule as invasive ductal carcinoma. This case highlights the inclusion of primary breast cancer in the differential diagnosis of extra-renal CAIX-avid lesions.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yan X, Xie Y, Liu M, et al. Incidental Detection of a CAIX-avid Breast Invasive Ductal Carcinoma on 68 Ga-NY104 PET/CT During Evaluation of a Suspected Renal Mass. Clin Nucl Med. 2026. PMID: 41945372. doi:10.1097/RLU.0000000000006375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。